So-Young
Chun
a,
Chanhee
Park
a,
Jiwon
Oh
b,
Hye-Jin
Yoon
c,
Tae-il
Kim
d,
Youngmi
Kim
d,
Seung Wook
Ham
e,
Hye Ran
Koh
e,
Hyung Ho
Lee
c,
Hun Young
Kim
*f and
Kyungsoo
Oh
*a
aCenter for Metareceptome Research, Graduate School of Pharmaceutical Sciences, Chung-Ang University, 84 Heukseok-ro, Dongjak, Seoul 06974, Republic of Korea. E-mail: kyungsoooh@cau.ac.kr
bDepartment of Integrative Energy Engineering, Graduate School of Energy and Environment (KU-KIST Green School), College of Engineering, Korea University, Seoul 02841, Republic of Korea
cDepartment of Chemistry, College of Natural Sciences, Seoul National University, Seoul 08826, Republic of Korea
dDepartment of Chemistry, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea
eDepartment of Chemistry, Chung-Ang University, 84 Heukseok-ro, Dongjak, Seoul 06974, Republic of Korea
fDepartment of Global Innovative Drugs, Chung-Ang University, 84 Heukseok-ro, Dongjak, Seoul 06974, Republic of Korea. E-mail: hunykim@cau.ac.kr
First published on 2nd January 2025
Correction for ‘(Thio)chromenone derivatives exhibit anti-metastatic effects through selective inhibition of uPAR in cancer cell lines: discovery of an uPAR-targeting fluorescent probe’ by So-Young Chun et al., Chem. Commun., 2025, https://doi.org/10.1039/D4CC05907G.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2025 |